Influenza vaccines that better target the influenza surface protein called neuraminidase (NA) could offer broad protection against various influenza virus strains and lessen the severity of illness, according to new research published in Cell.
Current seasonal influenza vaccines mainly target a different, more abundant influenza surface protein called hemagglutinin (HA). However, because influenza vaccines offer varying and sometimes limited protection, scientists are exploring ways to improve vaccine effectiveness. The new research builds on previous studies of NA and was conducted by a team of scientists including investigators from the Centers of Excellence for Influenza Research and Surveillance (CEIRS)program, which is organized and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Investigators analyzed blood samples from people vaccinated against influenza and people diagnosed with either the 2009 H1N1 influenza virus or H3N2 influenza viruses. The volunteers were recruited for this study or had taken part in prior influenza research studies. The analyses indicate that influenza vaccines rarely induce NA-reactive antibodies, whereas natural influenza infection induces these types of antibodies at least as often as they induce HA-reactive antibodies. Additional studies in mice reinforced the human data, indicating that current influenza vaccines do not induce NA-reactive antibodies efficiently.
Additional laboratory experiments show that the NA-reactive antibodies induced during natural influenza infection are broadly reactive, meaning they could potentially protect against diverse strains of influenza. To test this theory, scientists isolated NA-reactive monoclonal antibodies from the H3N2 and H1N1 influenza patients (N2-reactive antibodies and N1-reactive antibodies, respectively). They administered 13 N2-reactive antibodies to mice and subsequently infected the mice with a different H3N2 virus strain. Eleven of the 13 N2-reactive antibodies partially or fully protected the mice. They also administered eight N1-reactive antibodies to mice and subsequently infected the mice with a similar H1N1 virus strain or an H5N1-like virus strain. Four of the eight antibodies completely protected the mice against both virus strains.
The authors note that the findings suggest that influenza vaccines should be optimized to better target NA for broad protection against diverse influenza strains. In this regard, NIAID is supporting research to characterize NA responses in infected and vaccinated individuals and to determine the mechanism of action of NA protection. NIAID also supports “NAction!” a CEIRS working group that identifies knowledge gaps in our understanding of NA and sets NA research priorities for improved influenza vaccines. These efforts contribute to NIAID’s larger plan to develop a universal influenza vaccine—a vaccine that can durably protect all age groups against multiple influenza virus strains.
Learn more: Research Offers Clues for Improved Influenza Vaccine Design
The Latest on: Influenza
[google_news title=”” keyword=”influenza” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Influenza
- What’s Going Around: Scarlet fever, influenza, upper respiratory infections, stomach viruses, allergieson April 26, 2024 at 6:51 pm
Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local doctors and hospitals.
- Can You Get Bird Flu From Eggs and Milk? Everything to Know About Avian Influenzaon April 26, 2024 at 12:12 pm
The FDA says 20% of retail milk samples have tested positive for bird flu “viral fragments.” We asked a virologist and bird veterinarian what that means for dairy consumers.
- FDA finds traces of H5N1 bird flu viruses in grocery store milk but says pasteurized dairy products are still safeon April 26, 2024 at 10:39 am
The US Food and Drug Administration said Tuesday that it had detected viral particles of H5N1 avian influenza in milk purchased at grocery stores, but the agency says it still believes that the milk ...
- Mayo Clinic virologist offers perspective on avian influenza outbreakon April 26, 2024 at 9:34 am
Health officials around the globe, including the Centers for Disease Control and Prevention and the European Centre for Disease Control and Prevention, are monitoring the ongoing avian influenza ...
- Nationals being mindful with Ruiz in his return from influenzaon April 25, 2024 at 5:47 pm
Sidelined for 13 team games, Keibert Ruiz wanted to get back behind the plate. The starting catcher was wiped out, though. At the beginning of the Nationals' three-city West Coast road trip, Ruiz came ...
- Flu shot fatigue: influenza vaccination rates in R.I. continue to fall post-pandemicon April 25, 2024 at 2:30 am
Chalk it up to shot sickness, or maybe just an inflated sense of immunity. Either way, fewer Rhode Island adults rolled up their sleeves for a flu shot this year, though the state remains a national ...
- Dairy and Veterinary Experts from Iowa State to Give Update on Avian Influenza in Ruminantson April 23, 2024 at 1:38 pm
AMES, Iowa – The Iowa State University Extension and Outreach dairy team will host a second “virtual chat” to discuss the latest information on how Highly Pathogenic Avian Influenza (HPAI) is ...
- Influenza is considered the biggest pandemic threaton April 23, 2024 at 9:30 am
Influenza is viewed by infectious disease specialists as the pathogen with the highest pandemic potential, according to findings unveiled at a major global congress in Barcelona.
- Is There a Vaccine for H5N1 Influenza?on April 22, 2024 at 2:31 pm
On the heels of a multi-state outbreak of highly pathogenic avian influenza A (H5N1) in dairy cows, experts told MedPage Today that a trio of H5N1 vaccines for humans has already been developed and ...
via Bing News